| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | SUB11589p2_Spl07 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl08 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl09 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl14 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl15 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl16 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl20 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl21 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl22 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl10 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl11 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl12 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl17 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl18 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl19 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl23 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl24 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl25 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl32 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl33 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl34 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl35 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl36 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl37 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl26 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl27 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl28 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl29 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl30 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC POSITIVE ION MODE | SUB11589p2_Spl31 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl07 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl08 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl09 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl14 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl15 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl16 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl20 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl21 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl22 | cell line:ICC13-7 | treatment:control | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl10 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl11 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl12 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 0h as ctrl | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl17 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl18 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl19 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 1h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl23 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl24 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl25 | cell line:ICC13-7 | treatment:Infigratinib | labeling status:13C6-Glucose Isotopic tracing 24h | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl32 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl33 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl34 | cell line:ICC21 | treatment:Afatinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl35 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl36 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl37 | cell line:ICC21 | treatment:Combo | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl26 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl27 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl28 | cell line:ICC21 | treatment:control | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl29 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl30 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
| HILIC NEGATIVE ION MODE | SUB11589p2_Spl31 | cell line:ICC21 | treatment:Infigratinib | labeling status:N/A | area analyzed by Compound discoverer (counts x seconds) |
Return to study ST002835 main page
Download data matrix(Investigation of FGFR signaling controlled metabolism in FGFR2-fusion+ intrahepatic cholangiocarcinoma HILIC POSITIVE ION MODE)
Download data matrix(Investigation of FGFR signaling controlled metabolism in FGFR2-fusion+ intrahepatic cholangiocarcinoma HILIC NEGATIVE ION MODE)
- Metabolomics Workbench
|